1[1]Carter G, Lemoine NR. Antisense technology for cancer therapy : does it makes sense? [J]. Br J Cancer, 1993,67:869.
2[2]Neidle S, Kelland LR. Telomerase as an anti-cancer target:current status and future prospects[J]. Anticancer Drug Des, 1999,14(4): 341.
3[3]Shang JW,Bacchetti S. A survey of telomerase activity in human cancer[J]. Eur J Cancer, 1997,33 (5): 787.
4[4]Kim NW. Clinical implications of telomerase in cancer[J].Eur J Cancer,1997,33(5) :781.
5[5]Chang JT,Liao CT,Jung SM,et al. Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues[J]. Br J Cancer, 2000,82 (12) : 1946.
6[6]Feng J,Funk WD,Wang SS,et al. The RNA component of human telomerase[J]. Science, 1995,269:1236.
8[8]Takakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit(hTRT) gene promoter and identification of proximal core promoter sequence essential for transcriptional activation in immortalized and cancer cells]J]. Cancer Res,1999,59(3) :551.
9[9]Glukhov AI,Zimnik OV,Gordeer SA. Inhibition of telomerase activity of melanuma cells in vitro by antisense oligonucleotides[J]. Biochem Biophys Res Commun, 1998,248(2) :368.
10[10]Kushner DM, Paranjape JM, Bandyopadhyay B. 2 ～ 5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells[J]. Gynecol Oncol, 2000,76(2) :183.
